Multicentre Retrospective Study on the Clinical and Epidemiological Characteristics and Therapeutic Management of Non-cholera Vibrio Infections
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Vibrio Infections
- Sponsor
- Groupe Hospitalier de la Rochelle Ré Aunis
- Enrollment
- 67
- Locations
- 7
- Primary Endpoint
- Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to identify the epidemiological and clinical characteristics of patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019.
Detailed Description
Vibrios are gram-negative, ubiquitous bacteria of the marine flora and are found particularly in warm waters. For example, the incidence is high in Florida and Vibrio infections are now reportable in the United States. Different species of Vibrio are described. A distinction is made between choleric vibrios belonging to serogroups O1 and O139, responsible for cholera epidemics, and non-choleric vibrios. Our study will focus on non-cholera vibrios. Vibrio infections can occur by eating contaminated raw seafood or by exposure of a wound to the marine environment. They occur mainly during the hot summer months. This can be explained on the one hand by higher water temperature and on the other hand by increased beach use. With global warming, it is possible that Vibrio infections may increase in number and location.
Investigators
Eligibility Criteria
Inclusion Criteria
- •non-cholera Vibrio infection
Exclusion Criteria
- •vibriosis to Vibrio cholerae O1 and O139
Outcomes
Primary Outcomes
Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection
Time Frame: Up to 20 years, from 2000-2019
A non-cholerae or non-O1/O139 Vibrio infection was defined by a biological sample (blood, superficial sample, deep sample, and ear sample) positive to a Vibrio species other than Vibrio cholerae O1-O139.
Secondary Outcomes
- Number of Participants Associated With Environmental Factors(at inclusion)
- Number of Participants Per Identified Species(at inclusion)
- Number of Participants by Month of the Years(at inclusion)
- Number of Participants Treated by Antibiotics(through study completion, an average of 1 month)
- Number of Patients Per Clinical History(at inclusion)
- Number of Participants Per Outcome(through study completion, an average of 1 month)